Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Secukinumab

Brand: Cosentyx ┬«
NICE TA: 350
Indication: Moderate to Severe Plaque Psoriasis (NICE TA350)
Disease category: Skin
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Secukinumab is recommended, as an option for treating adults with plaque psoriasis as per NICE TA 350

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red